BHA is classified as possibly carcinogenic to humans based on animal studies showing forestomach tumors in rodents at high doses. Human studies are inconclusive and the relevance at typical exposure levels is debated.
BHA (Butylated Hydroxyanisole) has been classified as reasonably anticipated to be a human carcinogen based on animal studies, specifically the development of forestomach tumors in rodents when administered at high doses. While some animal studies have shown a link, human studies have been inconclusive and the relevance to human health at typical exposure levels remains debated. The mechanism of action is not fully understood, but it is thought to involve oxidative stress and DNA damage. The latency period for tumor development is typically long-term.
Key Information
Severity
High
Associated Ingredients
1 ingredient
Associated Ingredients
Important Safety Information
This information is for educational purposes only. Always consult with a healthcare professional before starting any new supplement regimen, especially if you experience any side effects.